Table 2. Outcome measures (primary and secondary).

Outcome measures (Median)	Citicoline (n = 49)	Placebo (n = 50)	P-value	OR with 95% CI
PRIMARY OUTCOME
Change in stroke volume from baseline to 6 weeks (cm 3 )	4.22	2.63	0.483
SECONDARY OUTCOME
mRS 0–2 at 90 days	32 (65.3%)	31 (62%)	0.732	0.92 (0.40–2.05)
NIHSS 0–2 at 90 days	20 (40.8%)	20 (40%)	0.934	0.96 (0.39–2.40)
Barthel index > = 95 at 90 days	8 (16.3%)	10 (20%)	0.564	0.87 (0.22–2.98)
Mortality rate at 90 days	10.2 (5/49)	14 (7/50)	0.468